On April 25, 2019, the UCLA Jonsson Comprehensive Cancer Center (JCCC) celebrated the naming of the Ali Jassim Family Cancer Research Suite in the South Tower of the UCLA Center for Health Sciences. Joined by family, friends and UCLA Health Sciences leadership, donor Ali Jassim, a member of the UCLA Jonsson Cancer Center Foundation Board of Directors, cut the ribbon to the laboratory suite that will provide a collaborative home to some of the JCCC’s most innovative researchers, whose studies have resulted in a remarkable 11 U.S. Food and Drug Administration approvals for new cancer therapies. A scientific forum immediately followed the dedication ceremony, during which faculty recipients of seed grants funded by Jassim spoke about their research efforts and the significance of philanthropy in advancing scientific discoveries.
For more information, contact Margaret Steele at: 310-794-5244
Left: (From left) Dr. Kelsey C. Martin, dean of the David Geffen School of Medicine at UCLA and Gerald S. Levey, M.D., Endowed Chair; Dr. John C. Mazziotta (RES ’81, FEL ’83), vice chancellor of UCLA Health Sciences and CEO of UCLA Health; Ali Jassim; Dr. Judith C. Gasson, senior advisor for research and innovation at the David Geffen School of Medicine at UCLA; and Dr. Michael Teitell (PhD ’91, MD ’93), director of the JCCC, president of the UCLA Jonsson Cancer Center Foundation and Lya and Harrison Latta Endowed Chair in Pathology. Right: Jassim (left) and UCLA Jonsson Cancer Center Foundation Board of Directors member Manizheh Yomtoubian.
Jassim (left) and UCLA Jonsson Cancer Center Foundation Board of Directors member Manizheh Yomtoubian.
